New Perspectives on the Management of Type 2 Diabetes

Abstract

Get full access to this article

View all access options for this article.

References

Sandbaek A. , Griffin SJ , Rutten G. , et al. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia 2008; 51: 1127-34.

Eborall HC , Griffin SJ , Prevost AT , et al. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 2007; 335:486-9.

Howard BV , Roman MJ , Devereux RB , et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 2008; 299:1678-89.

Cannon CP , Steinberg BA , Murphy SA , Mega JL , Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006; 48:438-45.

Colhoun HM , Betteridge DJ , Durrington PN , et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364:685-96.

Cholesterol Treatment Trialists' (CTT) Collaborators , Kearney PM , Blackwell L. , et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis . Lancet 2008; 371:117-25.

Kahn SE , Haffner SM , Heise MA , et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43.

Nauck M. , Meininger G. , Sheng D. , Terranella L. , Stein PP Sitagliptin Study 024 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. Diab Obes Metab 2007; 9:194-205.

Sinclair AJ , Conroy SP , Bayer AJ Impact of diabetes on physical function in older people. Diabetes Care 2008; 31:233-5.

10.

Shulman KI

Clock-drawing: is it the ideal cognitive screening test?

Int J Geriatr Psychiatry 2000; 15:548-61.

11.

Bellary S. , O'Hare JP , Raymond NT , et al. Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet 2008; 371:1769-76.

12.

Khunti K. , Gadsby R. , Millett C. , Majeed A. , Davies M. Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes. Diabet Med 2007; 24:1436-41.

13.

Campbell S. , Reeves D. , Kontopantelis E. , Middleton E. , Sibbald B. , Roland M. Quality of primary care in England with the introduction of pay for performance. N Engl J Med 2007; 357:181-90.

14.

Millett C. , Gray J. , Saxena S. , Netuveli G. , Khunti K. , Majeed A. Ethnic disparities in diabetes management and pay-for-performance in the UK: the Wandsworth Prospective Diabetes Study. PLoS Med 2007; 4:e191.